Centre Never Sought Oxygen Death Data: Rajasthan & Chhattisgarh

JAIPUR/RAIPUR : Two Congress-led states on Thursday refuted the Centre’s statement in Parliament that “no deaths due to lack of oxygen were specifically reported by the states” during the second wave of Covid-19.

The health ministers of Rajasthan and Chhattisgarh claimed their states were never asked to submit the relevant data and hence did not report the number of Covid deaths medically attributed to oxygen shortage.

Both questioned the basis of the Centre’s statement in Parliament when the relevant data wasn’t collected from the states. Rajasthan health minister Raghu Sharma said majority of the deaths during the second wave in the state were due to oxygen shortage.

The Centre, in a written statement on Tuesday, had informed the Rajya Sabha that states did not specifically report deaths due to oxygen shortage. In a series of tweets on Thursday, Chhattisgarh health minister TS Singh Deo pointed out that the “number of deaths in a day, deaths with comorbidity, deaths without comorbidity and type of comorbidity” were the only categories in which data was sought. Singh Deo alleged that the Centre deliberately misled Parliament without checking with the states. “When GOI says ‘no one died due to lack of oxygen during the second wave,’ they are probably referring to Chhattisgarh — a state with surplus oxygen,” added Singh Deo.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India